HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation.

AuthorsIgor Denizarde Bacelar Marques, Janaina Ramalho, Daísa Ribeiro David, William Carlos Nahas, Elias David-Neto
JournalInternational urology and nephrology (Int Urol Nephrol) Vol. 46 Issue 10 Pg. 2053-4 (Oct 2014) ISSN: 1573-2584 [Electronic] Netherlands
PMID25080208 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Biomarkers
  • Immunologic Factors
  • Rituximab
Topics
  • Antibodies, Monoclonal, Murine-Derived (therapeutic use)
  • B-Lymphocytes (immunology)
  • Biomarkers (urine)
  • Biopsy
  • Female
  • Glomerulonephritis, Membranoproliferative (immunology, therapy)
  • Humans
  • Immunologic Factors (therapeutic use)
  • Kidney Transplantation
  • Middle Aged
  • Plasmapheresis
  • Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: